BSD Medical Corp. (BSDM) reported signing an exclusive, long-term, multi-million dollar distribution agreement with Terumo Europe NV, an unit of Terumo Corp., (TRUMF.PK) for the MicroThermX Microwave Ablation System. As per the distribution deal, Terumo Europe NV would have the exclusive right to market MicroThermX in 100 countries in Europe, Western Asia, and Northern Africa. The potential market size for MicroThermX in these countries is projected to be more than $1 billion in annual sales.
According to the company, this agreement validates the large market opportunity for MicroThermX ablation products and is likely to drive market adoption for the MicroThermX as a leading ablation therapy system. Strategically, MicroThermX would benefit from Terumo Europe NV's extensive market reach, focus on interventional oncology, and well-established relationships with key interventional oncology opinion leaders throughout Europe, BSD Medical added.
For comments and feedback: editorial@rttnews.com